
Angstrom6
CAS No. 220334-14-5
Angstrom6( —— )
Catalog No. M34159 CAS No. 220334-14-5
Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the downstream effects.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 74 | Get Quote |
![]() ![]() |
5MG | 116 | Get Quote |
![]() ![]() |
10MG | 188 | Get Quote |
![]() ![]() |
25MG | 319 | Get Quote |
![]() ![]() |
50MG | 475 | Get Quote |
![]() ![]() |
100MG | 662 | Get Quote |
![]() ![]() |
500MG | 1332 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAngstrom6
-
NoteResearch use only, not for human use.
-
Brief DescriptionAngstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the downstream effects.
-
DescriptionAngstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling.
-
In Vitro——
-
In VivoAnimal Model:C57Bl/6 mice (bearing B16-F10 cells)Dosage:100 mg/kg Administration:S.c.; twice a day for 11 days Result:Reduced the number of lung nodules and reduced the number of lung metastases to 50% of control.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPAI-1
-
RecptorPAI-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number220334-14-5
-
Formula Weight910.97
-
Molecular FormulaC39H62N10O15
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (109.77 mM; Ultrasonic )H2O : ≥ 100 mg/mL (109.77 mM)
-
SMILESCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ghamande SA, et al. A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer. Gynecol Oncol. 2008;111(1):89-94.?
molnova catalog



related products
-
UK-371804
UK-371804 is a potent and selective inhibitor of urokinase-type plasminogen activator (uPA) with Ki of 10 nM.
-
Angstrom6
Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the downstream effects.
-
AZ3976
AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities.